Virtu Financial »

Brainstorm Cell Therapeutics shares owned by Virtu Financial

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Virtu Financial from 13F filings

Historical chart of Virtu Financial investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Virtu Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Virtu Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $19k 71k 0.27
2023-06-30 $22k 11k 2.02
2022-06-30 $57k 21k 2.75
2020-12-31 $111k 25k 4.53
2019-09-30 $51k 13k 3.92
2017-09-30 $52k 13k 4.14

More positions owned by Virtu Financial

Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Select Sector Spdr Tr Technology (XLK)
Meta Platforms Cl A (META)
Direxion Shs Etf Tr Drx S P500bull (SPXL)
Direxion Shs Etf Tr 20yr Tres Bear (TMV)
Vanguard Index Fds S P 500 Etf Shs (VOO)
Select Sector Spdr Tr Financial (XLF)
Synopsys (SNPS)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Altria (MO)
Hess (HES)
Pfizer (PFE)
News Corp Cl A (NWSA)
Invesco Currencyshares Cdn D CDN DLR SHS (FXC)

View all positions for Virtu Financial

Top funds holding Brainstorm Cell Therapeutics

Vanguard Group
Liberty Wealth Management
Weaver Consulting Group
Caldwell Sutter Capital
Abner, Herrman & BrocK
Raymond James & Associates
ADAR1 Capital Management
Ikarian Capital
Kingswood Wealth Advisors
Citadel Advisors
Virtu Financial
Jmac Enterprises
Barclays
Wells Fargo & Company
Saxony Capital Management

View all funds holding Brainstorm Cell Therapeutics